Keep up to date with the latest news and articles from Critical Care and BioMed Central.
Research
Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
Sandro B Rizoli*, Kenneth D Boffard, Bruno Riou, Brian Warren, Philip Iau, Yoram Kluger, Rolf Rossaint, Michael Tillinger and the NovoSeven® Trauma Study Group